Cost-Effectiveness of Increased Use of Dual Antiplatelet Therapy After High-Risk Transient Ischemic Attack or Minor Stroke.
Paul M WechslerAnkur PandyaNeal S ParikhJunaid Abdul RazzakHalina WhiteBabak Benjamin NaviHooman KamelAva L LibermanPublished in: Journal of the American Heart Association (2024)
Increasing DAPT use after TIAMIS with a QI intervention is cost-effective over a wide range of costs and proportion of patients with TIAMIS treated with DAPT after implementation of a QI intervention. Our results support the development of future interventions focused on increasing DAPT use after TIAMIS.
Keyphrases
- antiplatelet therapy
- acute coronary syndrome
- percutaneous coronary intervention
- randomized controlled trial
- cerebral ischemia
- atrial fibrillation
- primary care
- healthcare
- coronary artery disease
- physical activity
- current status
- ischemia reperfusion injury
- quality improvement
- brain injury
- subarachnoid hemorrhage
- oxidative stress